相关实验视频
Updated: Jun 24, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
稳态性肝病中的炎症:病原和治疗点
Shengying Qian1,2, Xiaolin Wang3, Yingfen Chen1,2
1Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, China.
研究与酒精有关的肝病 (ALD) 和与代谢功能障碍相关的脂肪性肝病 (MASLD) 中的免疫细胞,揭示了对肝炎的新见解. 了解这些特定的免疫细胞功能为脂肪性肝病 (SLD) 提供了潜在的新疗法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 与酒精有关的肝病 (ALD) 和与代谢功能障碍相关的脂肪性肝病 (MASLD) 是肝损伤的主要原因,从简单的脂肪症到肝细胞癌.
- 免疫细胞介导的炎症在脂肪性肝病 (SLD) 的发病过程中起着至关重要的作用,在过度或持续时会加剧肝损伤.
研究的目的:
- 审查关键免疫细胞在ALD和MASLD病变发生中的作用.
- 讨论SLD的基于炎症的治疗策略.
主要方法:
- 审查最近的文献,重点是单细胞和空间转录组分析.
- 在ALD和MASLD中分析免疫细胞异质性.
主要成果:
- 单细胞和空间转录组学揭示了ALD和MASLD中免疫细胞透的复杂异质性.
- 这些分析为SLDs提供了新的免疫病理学视角.
结论:
- 特定的免疫细胞种群及其功能在SLD病变发生过程中至关重要.
- 针对免疫机制,特别是特定的免疫细胞功能,为SLDs提供了有前途的治疗途径.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
07:12Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
相关概念视频
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Inflammation
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents